top of page

High quality, high margin, low cost African GACP cultivator poised for immediate and rapid growth!

Largest licensed cultivator in Africa! GACP, IMC-GAP, strong South Africa and U.S.-based ownership group, high-THC cultivars and industry-low cost structure will allow this global cannabis company to thrive under future price compression

Listing ID:

16412209311

Licence(s) Held:

Lesotho Operation Licence, IMC-GAP, GACP and CUMCS Certifications

16412209311

Seeking “smart money” strategic partner to invest up to $3 million USD; open to Board representation

Listing Details:

  • Well established, high margin, high quality, cannabis cultivator & exporter of medical THC flower poised for exponential growth

  • First-to-market for export of medical cannabis out of Africa; strategically positioned as a prime cornerstone within the global supply chain for premium, new trend cultivars

  • Led by an experienced South Africa and U.S.-based ownership group, world-class industry leaders and operational teams, the company boasts an industry low overhead cost structure and tax benefits

  • Currently undertaking cultivation, genetics/tissue culture, trimming, drying, propagation and bulk packaging, B2B sales and export into Israel

  • Company owns the largest medical cultivation cannabis licence in Africa with an initial high quality, state-of-the-art, 80,000 ft.² greenhouse, nestled within 370 acres of land

  • The site encompasses a new ~8500 ft.² post-harvest manufacturing facility adhering to EU GMP standards, as well as a centralized operation hub

  • The greenhouse facility possesses the capacity to yield 10,000 kg of premium dried flower annually

  • Established four premium, high quality cultivars, showcasing THC levels of 22% to 24.5% (to balance current global demand and restrictions regarding THC content.) In addition, efforts are underway to propagate additional unique strains.

  • In negotiations with several new purchase agreements and has strong commercial distribution leads in Australia, Germany, Poland, and South Africa

  • Largest physical footprint as the licence can accommodate 30 greenhouses plus vast outdoor grow

  • Anticipate pursuing EU GMP certification within the next 18 months. With the inclusion of a strategic partner, this process could be expedited within a shorter timeframe.

  • An exceptional prospect to collaborate with one of Africa's top-tier, dominant cultivators, presenting the opportunity to capture a substantial share of the market

  • Leveraging well-established infrastructure, attractive labor dynamics, gateway into the market and a pro-business, pro-cannabis governmental stance, the company provides a compelling proposition

  • Looking for “smart money” investors/partners characterized by strategic acumen, particularly those with a strong international presence, ideally within the EU

16412209311

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal
bottom of page